A Study of [89Zr]-Oxine-NCR100 Injection for the Cellular Distribution
Clinical trial NCT07139431 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07139431
- Sponsor
- Nuwacell Biotechnologies Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-29
- Primary completion
- 2026-03-06
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.